Forbion, a healthcare venture capital firm with centers in Germany and the Netherlands, recently announced that its portfolio company Staten Biotechnology B.V. and Denmark-based healthcare company Novo Nordisk A/S have collaborated and signed an exclusive option agreement in a bid to develop new therapeutics hypertriglyceridaemia …
Reports confirm that pharmaceutical company Novartis has withdrawn its application for marketing the drug canakinumab in Europe. The drug was aimed at preventing serious incidents like myocardial infarction (MI), stroke and death in patients that earlier had an MI. Apparently, this move came just a …
As a double blessing, the move will offer thousands of Kiwis access to new life-changing medicines. Pharmac (Pharmaceutical Management Agency), New Zealand’s crown entity that decides use of medicines and pharmaceutical products for public hospitals and community, has recently announced that it will fund Maviret, …
Ripple, a San Francisco-based technology company has reportedly entered into a partnership deal with GMT, Israel’s largest bank and the fifth largest financial institution in the world. Apparently, Ripple has been rigorously expanding its palette of partnerships, despite the crypto market hitting for a bottom. …
Reports confirm that the National Science Foundation (NSF) has inked a new cooperative agreement with nonprofit computer networking consortium Internet2. The collaboration is supposedly aimed at partnering with providers of commercial cloud computing and to support scientific applications in new, more effective uses of the …
The joint service will be launched in 13 cities across the world, giving Lime a lead over rival bike sharing startup Bird. Global tech behemoth, Google LCC has reportedly collaborated with bike and scooter sharing firm, Lime, to guide commuters to nearby bikes and scooters …
The collaboration will focus on developing biomarkers to detect diseases like cancer, liver disease, and IBD. Renowned microbiome drug developing firm, BiomX Ltd. has recently announced a collaboration with Johnson & Johnson’s Janssen Research & Development, LLC to exploit its microbiome-based biomarker discovery platform, XMarker. …
The investment will be used to enhance Ninjacart’s agri-tech platform and spread its reach in new markets India’s agri tech startup, Ninjacart has reportedly raised $35 million in a series B funding round led by Switzerland’s Syngeta Ventures and U.S.A.’s Accel Partners. Apparently, the new …
